Nifty Pharma Today: Index Performance, Stocks & Analysis

Updated: 13 Aug 2026 • 4:06 pm

Posted by:

Nifty Pharma Today: Index Performance, Stocks & Analysis

Nifty Pharma today closed on a mildly weak note, reflecting a session where losers outnumbered gainers even though a few stocks posted strong upside moves. The index stood at 26,686.8, down 75.7 points or 0.28% versus the previous close of 26,762.5. That makes the day important for anyone tracking sector performance today, because the headline fall was relatively small, but the internal breadth was softer than the index move alone suggests.

For traders and investors following Nifty Pharma live, the session showed a classic split market within the healthcare and pharma pack. A handful of names such as Natco Pharma, Gland Pharma and Ajanta Pharma advanced strongly, but broader weakness in stocks including JB Chemicals & Pharmaceuticals, Zydus Lifesciences, Abbott India and several heavyweight names kept the sector under pressure. This is why reading only the index level can be misleading; the stock-by-stock movement offers a much clearer picture.

At an index level, Nifty Pharma opened at 26,710.65, touched an intraday high of 26,712.35, and slipped to a low of 26,537.45 before settling at 26,686.8. The fact that the index traded close to its opening level on the upside but moved noticeably lower on the downside indicates that sellers had greater intraday control. In simple terms, buying interest was present in select counters, but it was not broad enough to overpower declines across the rest of the basket.

This detailed Nifty Pharma performance update covers the latest index snapshot, market breadth, complete constituent performance, top gainers, top losers, heavyweight stock behavior, a practical price-action read, and the key levels investors should monitor next. The analysis is based on available verified price and breadth data for 13 August 2026.

Table of Contents

Nifty Pharma Today: Sector Index Snapshot

Metric	Value
Current Value	26,686.8
Absolute Change	-75.7
Percentage Change	-0.28%
Opening Value	26,710.65
Previous Close	26,762.5
Today's High	26,712.35
Today's Low	26,537.45
Market Status	Closed
Last Updated	13 August 2026 at 4:00:00 PM IST
Market Trend	Bearish to sideways

The day’s summary is straightforward. Nifty Pharma fell modestly, but its intraday structure leaned negative because the index spent the session below the previous close and the low was meaningfully below the open. The narrow distance between open and high suggests there was limited follow-through buying after the market started. By contrast, the drop toward 26,537.45 shows that selling pressure had more room to expand during the day.

Even so, the decline was not severe. A 0.28% fall suggests this was not a panic-led selloff. Instead, it looked more like a selective correction inside the sector, where some stocks were firmly bought while others saw profit taking or underperformance. For users searching Nifty Pharma today or Nifty Pharma analysis, that distinction matters: the sector did weaken, but it was not a broad collapse.

Why Is Nifty Pharma Moving Today?

Based on the verified session data, the most visible reason behind Nifty Pharma’s movement today was the divergence across individual pharma stocks. When a sector index falls despite several strong gainers, it usually means two things happened at the same time: first, the number of declining stocks exceeded the number of advancing stocks; second, some influential stocks in the basket ended in the red.

That pattern was clearly visible today. Out of 20 constituents, 12 declined and only 8 advanced. In addition, several widely tracked heavyweight names such as Sun Pharmaceutical Industries, Divi's Laboratories, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India, Cipla and Aurobindo Pharma either slipped or stayed nearly flat. When multiple large and liquid stocks remain under pressure together, they can offset strong rallies in smaller pockets of the sector.

Another important point is the distribution of returns. The best gainers were impressive, with Natco Pharma up 3.98%, Gland Pharma up 2.64%, and Ajanta Pharma up 2.08%. But the losers were also significant, led by JB Chemicals & Pharmaceuticals at -3.87% and Zydus Lifesciences at -3.13%. This kind of split often keeps the headline index from moving decisively in either direction, especially when heavyweight stocks lean weak.

So, if someone asks why Nifty Pharma is falling today, the most fact-based answer is this: the sector saw broader selling than buying, and weakness in several heavyweight pharma stocks outweighed gains in a smaller set of outperformers. No additional macro or policy trigger is required to explain the day’s move from the verified numbers alone.

Market Breadth: What It Says About Sector Strength

Breadth Metric	Value
Advancing Stocks	8
Declining Stocks	12
Unchanged Stocks	0
Advance-Decline Ratio	0.67
Stocks in Green	40%
Stocks in Red	60%

Market breadth gives a deeper look at sector health than the index percentage alone. Today’s breadth in Nifty Pharma was negative. With only 8 stocks advancing against 12 decliners, the advance-decline ratio stood at 0.67. In plain language, for every 1 stock that rose, about 1.5 stocks fell.

This tells us the weakness was reasonably broad, even if not very deep at the index level. A negative breadth reading often indicates that the sector lacks widespread buying support. It can also show that gains are concentrated in a few counters rather than shared across the full basket. That is exactly what happened today, where standout winners did not represent the majority.

The 40% green versus 60% red split also matters for short-term interpretation. If the index had fallen with only a handful of names declining, the move would look more isolated. But when most constituents are down, the tone becomes softer. For investors, this breadth profile points to a cautious undertone inside the pharma space, even though selective strength remained visible.

Complete Nifty Pharma Constituent Performance

Company	CMP	Today's %	Today's Change	Day Open	Day High	Day Low	Trend
Natco Pharma Ltd.	951.7	3.98%	36.4	920.25	962	917.2	Positive
JB Chemicals & Pharmaceuticals Ltd.	2408.9	-3.87%	-97.1	2506	2525.5	2380	Negative
Zydus Lifesciences Ltd.	1167.3	-3.13%	-37.7	1201	1202.9	1163.5	Negative
Gland Pharma Ltd.	2967.6	2.64%	76.4	2891.1	2975	2825.5	Positive
Ajanta Pharma Ltd.	3614.6	2.08%	73.6	3544.8	3675	3540	Positive
Abbott India Ltd.	27620	-1.85%	-520	28610	28635	27400	Negative
Biocon Ltd.	420	-1.73%	-7.4	424.1	425.3	416.2	Negative
Ipca Laboratories Ltd.	1796.3	1.68%	29.7	1781	1905	1767.7	Positive
Lupin Ltd.	2250.3	-1.35%	-30.7	2268	2278	2250.3	Negative
Glenmark Pharmaceuticals Ltd.	2320	1.31%	30	2290.9	2322.9	2281.9	Positive
Mankind Pharma Ltd.	2404.4	-1.18%	-28.7	2430.5	2430.5	2392	Negative
Divi's Laboratories Ltd.	8500	-1.16%	-100	8539.5	8539.5	8414	Negative
Granules India Ltd.	857.55	-0.84%	-7.25	862	882	853	Negative
Sun Pharmaceutical Industries Ltd.	1932	-0.62%	-12	1943	1946.3	1931.1	Negative
Alkem Laboratories Ltd.	5449.5	-0.56%	-30.5	5459	5483	5406	Negative
Dr. Reddy's Laboratories Ltd.	1206	0.5%	6	1194	1208.1	1182.1	Positive
Torrent Pharmaceuticals Ltd.	4914.5	0.44%	21.5	4890.5	4914.5	4833	Positive
Cipla Ltd.	1458.8	-0.29%	-4.2	1458.1	1464.4	1456.2	Negative
Aurobindo Pharma Ltd.	1663.4	-0.22%	-3.6	1666	1682.4	1654.5	Negative
Laurus Labs Ltd.	1851.7	0.09%	1.7	1850	1851.7	1820.6	Positive

The complete constituent list shows a mixed but negative-leaning market. Natco Pharma was the top performer with a 3.98% rise, while JB Chemicals & Pharmaceuticals was the worst performer with a 3.87% decline. This spread between the best and worst names highlights meaningful stock-specific volatility inside the sector.

Another useful takeaway is that some stocks posted strong positive closes despite the index weakness. Gland Pharma, Ajanta Pharma, Ipca Laboratories and Glenmark Pharmaceuticals all gained more than 1%. That tells us buying appetite still existed in selected counters. However, the sector’s large and widely tracked companies did not provide enough support

overall, which kept Nifty Pharma in the red.

Top Gainers in Nifty Pharma Today

Company	Price Change	% Move	Session Read
Natco Pharma Ltd.	36.4	3.98%	Strongest performer in the index today
Gland Pharma Ltd.	76.4	2.64%	Solid upside with broad intraday range
Ajanta Pharma Ltd.	73.6	2.08%	Strong buying interest through the session
Ipca Laboratories Ltd.	29.7	1.68%	Healthy gain despite weak sector tone
Glenmark Pharmaceuticals Ltd.	30	1.31%	Positive follow-through close

The top gainers list is important because it explains why the index decline remained contained instead of becoming much larger. Natco Pharma led with a near 4% rise, clearly standing out as the strongest stock in the sector today. Gland Pharma and Ajanta Pharma also delivered robust moves above 2%, helping offset weakness elsewhere.

These gainers suggest that market participants were still willing to allocate to individual pharma names even in a softer sector session. In practical terms, this was not a day when the entire pharma space was sold indiscriminately. Rather, stock selection mattered. The strongest gainers likely acted as partial stabilizers for the overall index.

Top Losers in Nifty Pharma Today

Company	Price Change	% Move	Session Read
JB Chemicals & Pharmaceuticals Ltd.	-97.1	-3.87%	Sharpest decline in the index today
Zydus Lifesciences Ltd.	-37.7	-3.13%	Meaningful pressure from open to close
Abbott India Ltd.	-520	-1.85%	Large absolute price fall during the session
Biocon Ltd.	-7.4	-1.73%	Persistent weakness through the day
Lupin Ltd.	-30.7	-1.35%	Ended at day low, showing weak tone

The top losers reveal where the drag came from. JB Chemicals & Pharmaceuticals and Zydus Lifesciences posted the steepest declines, both falling more than 3%. Abbott India, despite a smaller percentage drop than the top two losers, saw a notable absolute fall in price. Biocon and Lupin also added to the negative tone.

What stands out here is not just the presence of losers, but their spread across the sector. This was not a one-stock event. Multiple names across different price bands ended lower, and that broad pressure matches the weak breadth reading. For anyone tracking Nifty Pharma losers today, this basket largely explains why the sector did not recover into the close.

Heavyweight Stocks and Their Impact on Nifty Pharma

Heavyweight Stock	CMP	% Change	Interpretation
Sun Pharmaceutical Industries Ltd.	1932	-0.62%	Large pharma name ended lower
Divi's Laboratories Ltd.	8500	-1.16%	Heavyweight weakness added pressure
Torrent Pharmaceuticals Ltd.	4914.5	0.44%	Offered limited support
Cipla Ltd.	1458.8	-0.29%	Near-flat but negative
Dr. Reddy's Laboratories Ltd.	1206	0.5%	One of few supportive large names
Mankind Pharma Ltd.	2404.4	-1.18%	Added to sector weakness
Zydus Lifesciences Ltd.	1167.3	-3.13%	Large decline hurt index tone
Lupin Ltd.	2250.3	-1.35%	Weak finish weighed on sentiment
Abbott India Ltd.	27620	-1.85%	Notable weakness in a high-priced constituent
Aurobindo Pharma Ltd.	1663.4	-0.22%	Soft but not sharply negative

The heavyweight list helps explain the gap between a few standout gainers and the index’s final decline. Several prominent names ended lower, including Sun Pharma, Divi's Laboratories, Cipla, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India and Aurobindo Pharma. When many of the sector’s key names fail to participate on the upside, the benchmark usually struggles to advance.

Torrent Pharmaceuticals and Dr. Reddy's Laboratories were among the relatively supportive heavyweights, but their gains were modest compared with the declines seen in some other major counters. This imbalance is one of the clearest ways to understand Nifty Pharma performance today.

Intraday Price Action and Technical Read

On available price data, Nifty Pharma’s technical picture for the day can be described as bearish to sideways. The index opened at 26,710.65 and the intraday high came at 26,712.35, which is only slightly above the opening print. That suggests upside momentum was limited early in the session.

The index then moved lower to 26,537.45 before recovering part of the fall and closing at 26,686.8. This closing level is above the day’s low, which shows some buying support emerged after the decline. However, because the close remained below the previous close and below the open, the short-term session structure still leaned weak.

From a plain-language chart perspective, the market spent the day searching for support after failing to build upward momentum. The distance between high and low was 174.9 points, showing there was enough volatility for active traders even though the final percentage move looked small. A close near the middle-to-upper portion of the day’s range, but below the open, often indicates partial stabilization rather than a full reversal.

For near-term tracking, investors can monitor whether the index begins to hold above the closing zone around 26,686.8 and whether fresh buying allows it to reclaim the opening zone near 26,710.65. On the downside, the day’s low of 26,537.45 becomes an immediate reference area because that is where buying interest appeared during the session. This is an observational price-action framework based only on the day’s verified levels.

Most Active and Most Watched Pharma Stocks

The most active and most watched names in the Nifty Pharma universe today included Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Cipla, Dr. Reddy's Laboratories, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India and Aurobindo Pharma. Even without volume figures displayed here, these are the names that matter most for broad sector tracking because they are central to market attention and index behavior.

Among them, the mixed pattern was clear. Sun Pharma, Divi's Laboratories, Cipla, Mankind Pharma, Zydus Lifesciences, Lupin, Abbott India and Aurobindo Pharma closed in the red, while Torrent Pharmaceuticals and Dr. Reddy's Laboratories ended in the green. This mixed heavyweight profile usually signals that the sector lacks a unified directional push.

For investors, watching these names is useful because they often shape whether Nifty Pharma outperforms or underperforms in subsequent sessions. If more of these key stocks turn positive together, the sector’s breadth can improve quickly. If they continue to weaken while only a few mid-pack stocks rise, the index may remain range-bound or soft.

What Should Investors Watch Next in Nifty Pharma?

The first thing to watch next is breadth. Today, 60% of the index constituents closed lower. If that ratio improves in the next session and more stocks join the gainers list, it would point to healthier sector participation. Breadth often changes before the headline index trend becomes obvious.

The second thing to monitor is whether today’s top gainers can sustain their strength. Natco Pharma, Gland Pharma, Ajanta Pharma, Ipca Laboratories and Glenmark Pharmaceuticals were the strongest names in the sector. If they continue to advance while heavyweights stabilize, Nifty Pharma could improve even without a major breakout.

The third area is the behavior of the large and influential stocks. Sun Pharma, Divi's Laboratories, Zydus Lifesciences, Lupin, Mankind Pharma, Abbott India and Cipla all closed lower or near flat. If this group remains weak, the index may find it difficult to build momentum. If they recover, the overall sector tone can shift quickly.

Finally, traders should keep an eye on the session’s own reference levels: the high of 26,712.35, the low of 26,537.45, and the close of 26,686.8. These levels summarize today’s balance between buyers and sellers. A move above the day’s high would signal improving short-term strength, while a break below the day’s low would indicate that sellers still control the trend.

Key Takeaways

Nifty Pharma today closed at 26,686.8, down 75.7 points or 0.28%.
The sector opened at 26,710.65, hit a high of 26,712.35, and a low of 26,537.45.
Market breadth was negative, with 8 gainers and 12 losers.
Natco Pharma was the top performer, rising 3.98%.
JB Chemicals & Pharmaceuticals was the worst performer, falling 3.87%.
Several heavyweights such as Sun Pharma, Divi's Laboratories, Zydus Lifesciences, Lupin and Abbott India ended lower.
Strong gains in select stocks limited the downside, but broader participation remained weak.
The day’s tone can best be described as mildly bearish with stock-specific strength.

Featured Snippet Answers

What is Nifty Pharma?

Nifty Pharma is a sectoral stock market index that tracks listed pharmaceutical companies in the Indian market. It helps investors assess how the pharma sector is performing as a group rather than through a single stock.

Why is Nifty Pharma moving today?

Nifty Pharma moved lower today because more constituent stocks declined than advanced, and several heavyweight pharma names ended in the red. Gains in a few strong stocks were not enough to lift the full index.

Which stock contributed the strongest positive move today?

Natco Pharma was the strongest stock in Nifty Pharma today, rising 3.98% to 951.7. Other notable gainers included Gland Pharma and Ajanta Pharma.

Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals was the top loser in Nifty Pharma today, declining 3.87% to 2,408.9. Zydus Lifesciences was the next major laggard.

How many stocks advanced today in Nifty Pharma?

Eight stocks advanced today in Nifty Pharma, while 12 declined. That resulted in an advance-decline ratio of 0.67 and showed weaker overall sector breadth.

Google AI Overview Summary

Nifty Pharma today closed at 26,686.8, down 0.28% from the previous close. The sector’s movement was shaped by negative breadth, with 12 decliners against 8 gainers. Strong upside in Natco Pharma, Gland Pharma and Ajanta Pharma was offset by declines in JB Chemicals & Pharmaceuticals, Zydus Lifesciences, Abbott India and several heavyweight stocks including Sun Pharma and Divi's Laboratories. Investors may watch whether breadth improves, whether heavyweight names stabilize, and whether the index holds above its intraday low of 26,537.45 in the next session.

Published on 13 August 2026 at 4:04 PM IST

Frequently Asked Questions

1. What is the Nifty Pharma index today?

Nifty Pharma today closed at 26,686.8, down 75.7 points or 0.28% from the previous close of 26,762.5.

2. Why is Nifty Pharma falling today?

Nifty Pharma fell today because 12 of its 20 constituents declined, and several heavyweight stocks ended lower, outweighing gains in a smaller group of outperformers.

3. What was the opening value of Nifty Pharma today?

Nifty Pharma opened at 26,710.65 on 13 August 2026.

4. What were the day high and day low of Nifty Pharma?

The index touched an intraday high of 26,712.35 and a low of 26,537.45 during the session.

5. Which stock was the top gainer in Nifty Pharma today?

Natco Pharma was the top gainer in Nifty Pharma today, rising 3.98% to close at 951.7.

6. Which stock was the top loser in Nifty Pharma today?

JB Chemicals & Pharmaceuticals was the top loser in the index today, falling 3.87% to 2,408.9.

7. How many Nifty Pharma stocks advanced today?

Eight stocks advanced in Nifty Pharma today.

8. How many Nifty Pharma stocks declined today?

Twelve stocks declined in Nifty Pharma today.

9. What is the advance-decline ratio of Nifty Pharma today?

The advance-decline ratio of Nifty Pharma today was 0.67, indicating more losers than gainers.

10. Which major pharma stocks were under pressure today?

Sun Pharma, Divi's Laboratories, Zydus Lifesciences, Lupin, Mankind Pharma, Abbott India, Cipla and Aurobindo Pharma were among the notable stocks that ended lower.

11. Which major pharma stocks supported the index today?

Natco Pharma, Gland Pharma, Ajanta Pharma, Ipca Laboratories, Glenmark Pharmaceuticals, Dr. Reddy's Laboratories and Torrent Pharmaceuticals were among the main supporting stocks.

12. What should investors watch next in Nifty Pharma?

Investors can watch whether sector breadth improves, whether heavyweight stocks recover, and whether the index holds above 26,537.45 or moves back above 26,712.35 in the next session.

Disclaimer

Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.